Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a woman has both Frontal Fibrosing Alopecia and Lichen Simplex Chronicus, a previously unreported combination of conditions.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Current treatments for cicatricial alopecia can manage symptoms but don't stop hair loss or the disease.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

The patient has frontal fibrosing alopecia (FFA).

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

Dermoscopy helps diagnose frontal fibrosing alopecia by identifying specific scalp features.

A condition called Central Centrifugal Cicatricial Alopecia causes hair loss and scalp burning in middle-aged African women, and it's treated with various medications, hair transplants, and non-drug methods like wigs.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

The authors suggest a method for hair transplantation in fibrosing alopecia pattern distribution to improve treatment outcomes and cover bald areas.

A woman with CCCA has hair loss due to factors like straighteners and tight hairstyles, and treatments include steroids and avoiding certain hair products.

A rare skin condition causing scarring was successfully treated with topical erythromycin and benzoyl peroxide.

Elastin staining helps assess late-stage scarring alopecia but is not definitive, and clinical diagnosis is still crucial.

Hair restoration surgery can potentially treat primary scarring alopecias, but it's important to start early medication, ensure patient remission before transplant, and monitor after surgery.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Hair loss in black women needs more research, early intervention, and community education.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.